Print Page | Contact Us | Sign In | Join
Industry News: News

FDA Approves Eskata for Raised Seborrheic Keratoses

Monday, December 18, 2017   (0 Comments)
Share |

The FDA has approved a topical, high-concentration hydrogen peroxide solution for raised seborrheic keratoses, according to a company press release.

Aclaris Therapeutics announced that the Food and Drug Administration (FDA) has approved Eskata (hydrogen peroxide) topical solution for the treatment of raised seborrheic keratoses.

Eskata is a high-concentration hydrogen peroxide-based topical solution intended for application in office by a healthcare provider. The pen-like applicator allows for a direct treatment application.

>>Read More

Contact Us

224 N Desplaines, Ste. 600S
 Chicago, IL 60661

Phone: 312-981-0993

Fax: 888-827-8860


AmSpa provides legal, compliance, and business resources for medical spas and medical aesthetic practices.

Follow Us: